← Back to Search

Cancer Vaccine

Early Detection Blood Test for Cancer

N/A
Waitlist Available
Led By Elizabeth ODonnell, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 45
Be older than 18 years old
Must not have
Individuals diagnosed with invasive malignancy within 3 years of enrollment (non-melanoma skin cancer is acceptable)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 months
Awards & highlights

Summary

This trial aims to see if a new blood test called GRAIL Galleri MCED can detect various types of cancer early in military veterans.

Who is the study for?
This trial is for veterans who have served in active military duty and are interested in early cancer detection. Specific eligibility criteria are not provided, but typically participants would need to be at a higher risk of developing cancer.
What is being tested?
The study is testing the GRAIL Galleri multi-cancer early detection (MCED) blood test, which aims to identify various types of cancers before symptoms appear by analyzing DNA in the participant's blood.
What are the potential side effects?
As this intervention involves a non-invasive blood test, side effects are minimal and may include discomfort or bruising at the needle site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 45 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was diagnosed with cancer other than non-melanoma skin cancer in the last 3 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Negative predictive value at 12 Months
Number of Participants Needed to Screen at 12 months
Positive predictive value at 12 Months
+2 more
Secondary study objectives
Cancer Detection Rate Comparison
Change in PROMIS Anxiety Short Form Score
Change in PROMIS Global Health Score
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Galleri MCED TestExperimental Treatment1 Intervention
Enrolled participants will complete: * Baseline visit with blood draw and questionnaires * Return of study test result * Online post-test questionnaire * For a positive result, diagnostic work-up could include clinic visits, biopsy, surgery, imaging assessments such as ultrasound, Computed Tomography (CT) scans, or Magnetic Resonance Imaging (MRI) scans. If no cancer is found upon work up, a repeat MCED test may be ordered at the discretion of the principle investigator for up to 1 year from the initial MCED blood test. * Follow-up for a negative MCED blood test could include a repeat test ordered by the principle investigator for up to 1 year from the initial MCED test or a survey or phone call by study staff approximately 1 year after the initial MCED blood test. * Online post-diagnostic questionnaire.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,100 Previous Clinical Trials
351,597 Total Patients Enrolled
United States Department of DefenseFED
891 Previous Clinical Trials
330,978 Total Patients Enrolled
Elizabeth ODonnell, MDPrincipal InvestigatorDana-Farber Cancer Institute
1 Previous Clinical Trials
1,000 Total Patients Enrolled
~1000 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top